Extracellular levels of glutamate and aspartate in the entopeduncular nucleus of the rat determined by microdialysis: Regulation by striatal dopamine D2 receptors via the indirect striatal output pathway?

Brain Research

Volumn 753, Issue 1, 1997, Pages 163-175

  Biggs, Christopher S ^a   Fowler, Leslie J ^a   Whitton, Peter S ^a   Starr, Michael S ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

6 hydroxydopamine; aspartate; entopeduncular nucleus; glutamate; microdialysis; reserpine

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ASPARTIC ACID; DOPAMINE 2 RECEPTOR; EXCITATORY AMINO ACID; GLUTAMIC ACID; HALOPERIDOL; LEVODOPA; N (3 HYDROXYPHENETHYL) N (PHENETHYL)PROPYLAMINE; OXIDOPAMINE; RACLOPRIDE; RESERPINE; VERATRIDINE;

ANIMAL EXPERIMENT; ARTICLE; CORPUS STRIATUM; ENTOPEDUNCULAR NUCLEUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ASPARTIC ACID; CORPUS STRIATUM; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; GLUTAMIC ACID; HYPOTHALAMUS; MALE; MICRODIALYSIS; NEURAL PATHWAYS; OXIDOPAMINE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RESERPINE; VERATRIDINE;

EID: 0030912497     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00033-4     Document Type: Article

References (72)

1. Albin, R.L., Aldridge, J.W., Young, A.B. and Gilman, S., Feline subthalamic nucleus neurons contain glutamate-like but not GABA-like or glycine-like immunoreactivity, Brain Res., 491 (1989) 185-188.
2. Albin, R.L., Makowiec, R.L., Hollingsworth, Z.R., Dure, L.S., Penney, J.B. and Young, A.B., Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study, Neuroscience, 46 (1992) 35-48.
3. Albin, R.L., Young, A.B. and Penney, J.B., The functional anatomy of basal ganglia disorders, Trends Neurosci., 12 (1989) 366-375.
4. 2 agonist-induced rotation in 6-hydroxydopamine-lesioned rats, Brain Res., 588 (1992) 307-310.
5. Beckstead, R.M., A reciprocal axonal connection between the subthalamic nucleus and the neostriatum in the cat, Brain Res., 275 (1983) 137-142.
6. Bergman, H., Wichmann, T. and DeLong, M.R., Reversal of experimental parkinsonism by lesions of the subthalamic nucleus, Science, 249 (1990) 1436-1438.
7. Biggs, C.S., Pearce, B.R., Fowler, L.J. and Whitton, P.S., The effect of sodium valproate on extracellular GABA and other amino acids in the rat ventral hippocampus: an in vivo microdialysis study, Brain Res. 594 (1992) 138-142.
8. Breese, G.R., Baumeister, A.A., Napier, T.C., Frye, G.D. and Mueller, R.A., Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine, J. Pharmacol. Exp. Ther., 235 (1985) 287-295.
9. Brotchie, J.M., Mitchell, I.J., Sambrook, M.A. and Crossman, A.R., Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate, Mov. Disord., 6 (1991) 133-138.
10. Carpenter, M.B., Carleton, S.C., Keller, J.T. and Conte, P., Connections of the subthalamic nucleus in the monkey, Brain Res., 224 (1981) 1-29.
11. Carretta, D., Sbriccoli, A., Santarelli, M., Pinto, F., Granato, A. and Minciacchi, D., (1996) Crossed thalamo-cortical and cortico-thalamic projections in adult mice, Neurosci. Lett., 204 (1996) 69-72.
12. Chéramy, A., Nieoullon, A. and Glowinski, J., Effects of the unilateral nigral application of baclofen on dopamine release in the two caudate nuclei of the cat, Eur. J. Pharmacol., 58 (1979) 133-140.
13. Crossman, A.R., Mitchell, I.J., Brotchie, J.M., Aziz, T.Z., Graham, W.C., Robertson, R. and Sambrook, M.A., Excitatory amino acid transmission of subthalamic nucleus efferents: relationship to hyperkinetic movement disorders and to parkinsonism. In R.P. Simon (Ed.), Excitatory Amino Acids, Thieme, New York, 1992, pp. 199-202.
14. Deniau, J.M., Hammond, C., Chevalier, G. and Féger, J., Evidence for branched subthalamic nucleus projections to substantia nigra, entopenduncular nucleus and globus pallidus, Neurosci. Lett., 9 (1978) 117-121.
15. Engber, T.M., Susel, Z., Kuo, S. and Chase, T.N., Chronic levodopa treatment alters basal and dopamine agonist-stimulated cerebral glucose utilization, J. Neurosci., 10 (1990) 3889-3895.
16. 2 agonists RU 24213 and RU 24926 are also kappa-opioid receptor antagonists, Neuropharmacology, 30 (1991) 409-412.
17. Fuller, T.A., Russchen, F.T. and Price, J.L., Sources of presumptive glutamatergic/aspartergic afferents to the rat ventral striatopallidal region, J. Comp. Neurol., 25 (1987) 317-338.
18. Gerfen, C.R., The neostriatal mosaic: multiple levels of compartmental organization, Trends Neurosci., 15 (1992) 133-139.
19. 2 dopamine receptor-regulated gene experssion of striatonigral and striatopalldial neurons, Science, 250 (1990) 1429-1432.
20. Gerfen, C.R., McGinty, J.F. and Young, W.S., Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis, J. Neurosci., 11 (1991) 1016-1031.
21. Gerfen, C.R. and Young, W.S., Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study, Brain Res., 460 (1988) 161-167.
22. Girault, F.A., Barbeito, L., Spampinato, U., Gozlan, H., Glowinski, J. and Besson, M.-J., In vivo release of endogenous amino acids from the rat striatum: further evidence for a role of glutamate and aspartate in corticostriatal neurotransmission, J. Neurochem., 47 (1986) 98-106.
23. Graybiel, A.M. and Ragsdale, C.W., Biochemical anatomy of the striatum. In P.C. Emson (Ed.), Chemical Neuroanatomy, Raven Press, New York, 1983, pp. 427-504.
24. Greenamyre, J.T., Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's disease, J. Neural Transm. [Gen. Sect.], 91 (1993) 255-269.
25. Herrera-Marschitz, M., Goiny, M., You, Z.-B., Meana, J.J., Petterson, E., Rodriguez-Puertas, R., Xu, Z-Q., Terenius, L., Hökfelt, T. and Ungerstedt, U., On the release of glutamate and aspartate in the basal ganglia of the rat: interactions with monoamines and neuropeptides, Neurosci. Biobehav. Rev., (1996), in press.
26. Herrera-Marschitz, M., Meana, J.J., Hökfelt, T., You, Z-B., Morino, P., Brodin, E. and Ungerstedt, U., Cholecystokinin is released from a crossed corticostriatal pathway, Neuroreport, 3 (1992) 905-908.
27. Hill, M.P. and Brotchie, J.M., Modulation of glutamate release by a κ-opioid receptor agonist in rodent and primate striatum, Eur. J. Pharmacol., 281 (1995) R1-R2.
28. Jackson, A. and Crossman, A.R., Subthalamic projection to nucleus tegmenti pedunculopontinus in the rat, Neurosci. Lett., 22 (1981) 17-22.
29. Jackson, A. and Crossman, A.R., Subthalamic nucleus efferent projection to the cerebral cortex, Neuroscience, 6 (1981) 2367-2377.
30. Jacobson, I. and Hamberger, A., Veratridine-induced release in vivo and in vitro of amino acids in the rabbit olfactory bulb, Brain Res., 299 (1984) 103-112.
31. Kaur, S. and Starr, M.S., Differential effects of intrastriatal and intranigral injections of glutamate antagonists on motor behaviour in the reserpine-treated rat, Neuroscience, (1996), in press.
32. Klockgether, T. and Turski, L., NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats, Ann. Neurol., 28 (1990) 539-546.
33. Klockgether, T., Turski, L., Honoré, T., Zhang, Z., Gash, D.M., Kurlan, R. and Greenamyre, J.T., The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine depleted rats and MPTP treated monkeys, Ann. Neurol., 30 (1991)717-723.
34. Le Moine, C., Normand, E., Guitteny, A.F., Fouque, B., Teoule, R. and Bloch, B., Dopamine receptor gene expression by enkephalin neurons in rat forebrain, Proc. Natl. Acad. Sci., 87 (1990) 230-234.
35. Leviel, V., Chéramy, A., Nieoullon, A. and Glowinski, J., Symmetric bilateral changes in dopamine release from the caudate nuclei of the cat induced by unilateral nigral application of glycine and GABA-related compounds, Brain Res., 175 (1979) 259-270.
36. Lindefors, N. and Ungerstedt, U., Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons, Neurosci. Lett., 115 (1990) 248-252.
37. Martin, J.P., Hemichorea resulting from a local lesion of the brain (syndrome of body of Luys), Brain, 50 (1927) 637-651.
38. Miller, W.C. and DeLong, M.R., Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism, In M.B. Carpenter and A. Jayaraman (Eds.), The Basal Ganglia II., Plenum Press, New York, 1987, pp. 415-427.
39. Mink, J.W. and Thach, W.T., Basal ganglia intrinsic circuits and their role in behavior, Curr. Opin. Neurobiol., 3 (1993) 950-957.
40. Mitchell, I.J., Clarke, C.E., Boyce, S., Robertson, R.G., Peggs, D., Sambrook, M.A. and Crossman, A.R., Neural mechanisms underling parkinsonian symptoms in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Neuroscience, 32 (1989) 213-226.
41. 3H]glutamate binding sites in rat brain, J. Neurosci., 11 (1985) 2909-2919.
42. Naito, A. and Kita, H. The cortico-pallidal projection in the rat: An anterograde tracing study with biotinylated dextran amide, Brain Res., 653 (1994) 251-257.
43. Orosz, D. and Bennett, J.P., Simultaneous microdialysis in striatum and substantia nigra suggests that the nigra is a major site of action of L-dihydroxyphenylalanine in the 'hemiparkinsonian' rat, Exp. Neurol., 115 (1992) 388-393.
44. Ossowska, K., The role of excitatory amino acids in experimental models of Parkinson's disease, J. Neural Transm. [P.D. Sect.], 8 (1994) 39-71.
45. Pan, H.S. and Walters, J.R., Unilateral lesion of the nigrostriatal pathway decreases the firing rate and alters the firing pattern of globus pallidus neurons in the rat, Synapse, 2 (1988) 650-659.
46. Papa, S.M., Engber, T.M., Boldry, R.C. and Chase, T.N., Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists, Eur. J. Pharmacol., 232 (1993) 247-253.
47. Parent, A. and Hazrati, L.-N., Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop, Brain Res. Rev., 20 (1995) 91-127.
48. Parent, A. and Hazrati, L.-N., Functional anatomy of the basal ganglia. II. The place of the subthalamic nucleus and external pallidum in basal ganglia circuitry, Brain Res. Rev., 20 (1995) 128-154.
49. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1982.
50. Riederer, P., Lange, K.W., Kornhuber, J. and Danielczyk, W., Glutamatergic-dopaminergic balance in the brain, Drug Res., 42 (1992) 265-268.
51. Rinvik, E. and Ottersen, O.P., Terminals of subthalamonigral fibres are enriched with glutamate-like immunoreactivity: an electron microscopic, immunogold analysis in the cat, J. Chem. Neuroanat., 6 (1993) 19-30.
52. Robertson, G.S. and Robertson, H.A., D1 and D2 dopamine agonist synergism: separate sites of action, Trends Pharmacol. Sci., 8 (1987) 295-299.
53. Robertson, G.S. and Robertson, H.A., Evidence that L-Dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms, J. Neurosci., 9 (1989) 3326-3331.
54. Robledo, P. and Féger, J., Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiological data, Brain Res., 518 (1990) 47-54.
55. Sarre, S., Herregodts, P., Deleu, D., Devrieze, A., De Klippel, N., Ebinger, G. and Michotte, Y., Biotransformation of L-DOPA in striatum and sunstantia nigra of rats with a unilateral, nigrostriatal lesion: a microdialysis study, Naunyn-Schmiedeberg's Arch. Pharmacol, 346 (1992) 277-285.
56. Schmidt, W.J., Bubser, M. and Hauber, W., Behavioural pharmacology of glutamate in the basal ganglia, J. Neural Transm. [Suppl.], 38 (1992) 65-89.
57. Sellal, F., Hirsch, E., Lisovoski, F., Mutschler, V., Collard, M. and Marescaux, C., Contralateral disappearance of parkinsonian signs after subthalamic hematoma, Neurology, 42 (1992) 255-256.
58. Smith, Y. and Parent, A., Neurons of the subthalamic nucleus in primates display glutamate but not GABA immunoreactivity, Brain Res., 453 (1988) 353-356.
59. Standaert, D.G., Testa, C.M., Young, A.B. and Penney, J.B., Organization of the N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat, J. Comp. Neurol., 343 (1994) 1-16.
60. 2 balance in the basal ganglia and its relevance to Parkinson's disease, Synapse, 19 (1995) 264-293.
61. Starr, M.S., Antiparkinsonian actions of glutamate antagonists -alone and with L-DOPA: a review of evidence and suggestions for possible mechanisms, J. Neural Transm., 10 (1995) 141-185.
62. 2 dopamine receptors in non-habituated mice, Neuropharmacology, 26 (1987) 613-619.
63. St-Pierre, J.-A. and Bédard, P.J., Intranigral but not intrastriatal microinjection of the NMDA antagonist MK-801 induced contralateral circling in the 6-OHDA rat model, Brain Res., 660 (1994) 255-260.
64. Svennilson, E., Torvik, A., Lowe, R. and Leksell, L., Treatment of parkinsonism by stereotaxic thermolesions in the pallidal region, Acta Psychiatr. Neurol. Scand., 35 (1960) 358-377.
65. 2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesions, J. Neuroscl, 7 (1987) 2927-2935.
66. Van der Kooy, D. and Hattori, T., Single subthalamic nucleus neurons project to both the globus pallidus and substantia nigra in rat, J. Comp. Neurol., 192 (1980) 751-768.
67. Westerink, B.H.C., Hofsteede, H.M., Damsma, G. and De Vries, J.B., The significance of extracellular calcium for the release of dopamine, acetylcholine and amino acids in conscious rats, evaluated by brain microdialysis, Naunyn-Schmiedeberg's Arch. Pharmacol., 337 (1988) 373-378.
68. White, L.E., Hodges, H.D., Carnes, K.M., Price, J.L. and Dubinsky, J.M., Colocalization of excitatory and inhibitory neurotransmitter markers in striatal projection neurons in the rat, J. Comp. Neurol., 339 (1994) 328-340.
69. Whitton, P.S., Biggs, C.S., Pearce, B.R. and Fowler, L.J., MK-801 increases extracellular 5-hydroxytrptamine in rat hippocampus and striatum in vivo, J. Neurochem., 58 (1992) 1573-1575.
70. You, Z.-B., Pettersson, E., Herrera-Marschitz, M., Hökfelt, T., Terenius, L., Nylander, I., Goiny, M., Hughes, J., O'Connor, W. and Ungerstedt, U., Modulation of striatal aspartate and dynorphin B release by cholecystokinin (CCK-8) studied in vivo with microdialysis, Neuroreport, 5 (1994) 2310-2304.
71. Young, W.S., Bonner, T.I. and Brann, M.R., Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain, Proc. Natl. Acad. Sci., 83 (1986) 9827-9831.
72. Zukin, R.S., Eghbali, M., Olive, D., Unterwald, E.M. and Tempel, A., A characterisation and visualisation of rat and guinea pig brain kappa opioid receptors: evidence for kappa 1 and kappa2 opioid receptors, Proc. Natl. Acad. Sci., 85 (1988) 4061-4065.